How we know
Every link on this study, and who decided it
The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.
4 links2 made here, not in the record5 judgments2 judges (our rules as one)0 record changes seen
Claude Opus 5.5Our rulesMade here
Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.
Trastuzumab
Made here1 judgment on this linkNCT07003074gives it, found by reading the recordTrastuzumabDefined by Claude Opus 5.5Nov 2, 2026, 3:40 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judgedAll judgments on this study
| When | Link | Judge | Decision | State |
|---|---|---|---|---|
| Nov 2 | Trastuzumabmade here | Claude Opus 5.5 | Comparator | Current |
| Nov 3 | Pertuzumabmade here | Claude Opus 5.5 | Comparator | Current |
| Nov 14 | Breast Neoplasms | Our condition-kind rule | Finest filed term | Current |
| Nov 18 | Anti-HER2/Topoisomerase I Inhibitor ADC TQB2102 | Our role rule | Tested | Current |
| As of now | Breast Neoplasms | Our main-condition rule (R9) | Main condition | Current |